Four successful campaigns over 1 million were recently launched on Mamacrowd

Mamacrowd, the leading platform in Italy with a total collection of $52.6 million (€44 million) for 90 funded companies, in this glimpse of 2021 is showing that it wants to raise the cut of its offers. Although the average collection was already among the highest in Italy ($585,000 (€490,000) on average), this year the platform is focusing heavily on millionaire collections. There are four campaigns that have just closed or are in progress that have abundantly exceeded one million, in addition to the ALIcrowd operation.

Read more about the latest successful crowdfunding campaigns launched by Mamacrowd and read other interesting business news, with our companion app, Born2Invest.

Etilika

Etilika.it is an innovative startup that launched e-commerce specialized in the nationwide online sale of Italian wines, champagnes, and spirits. Launched in July 2019, Etilika.it in less than a year and a half has achieved a prominent position that places its e-commerce among the main Italian players in the sector, without receiving any external investment. 

The startup, with about 1,500 labels processed, to which about 100 are added every month and thanks to its efficient internal logistics, which has managed picking & packing of more than 35,000 packages, will close 2020, just a year and a half after its launch, with an expected turnover of about $3.1 million (€2.6 million) compared to $239,000 (€200,000) in the second half of 2019.

Etilika’s campaign successfully closed last March 5th with a collection of more than $1.43 million (€1.2 million).

LifeGate

LifeGate S.p.A. – a benefit company – is an SME created in 2000 by the Roveda family, following the experience and the Exit matured with Fattoria Scaldasole, with a clear objective: to become the main Public Company for sustainable development. Born as a media company focused on sustainability issues, the company has become known especially thanks to the radio channel LifeGate Radio and now boasts a community of over 5 million people thanks to its website, radio, social media and mobile app channels.

In recent years, the activities and services have constantly evolved, combining editorial products and media, consulting and services to businesses, the design and development of concrete sustainability projects, the supply of 100% energy from renewable sources “Made in Italy”.

On the occasion of its twentieth anniversary, LifeGate has decided to start a process of transformation of the company into a “public company”, offering to anyone who believes in sustainability issues the opportunity to become a partner.

The Lifegate round, which will be open until next March 31st, has already raised over $2.15 million (€1.8 million).

Prometheus

Prometheus is an innovative medtech startup founded in 2017 that creates solutions for regenerative medicine and aims to integrate advanced technologies in the treatment of difficult-to heal skin wounds, such as pressure sores and diabetic ulcers.

The startup has developed Ematik, a customized, bioresorbable patch that combines a patient’s own blood with special biomaterials to treat difficult wounds. The patch halves wound healing time by stimulating regeneration, without scar formation. The market for wound care products is worth € 20 billion, with an annual growth rate of advanced products of 25%, a sign that advanced therapies will increasingly replace the use of traditional products.

Ematik has already demonstrated its effectiveness on numerous animal clinical cases, in fact, it is already on the veterinary market since February 2020 for the treatment of wounds of dogs, cats and horses. The technology is also covered by 3 patents, which will be extended worldwide.

The Prometheus campaign is open until April 7th and has raised over $1.8 million (€1.5 million) so far.

Homepal

Founded in 2014 by Andrea Lacalamita, Fabio Marra, Monica Regazzi and a group of managers and entrepreneurs, Homepal is an innovative SME that was created with the aim of transferring the advantage of technology to customers, who can manage, with savings of over 50% compared to traditional agencies, the sale and purchase of residential real estate.

Homepal, which closed 2020 with a net turnover of $2.4 million (€2 million), now has 80 thousand sales ads. More than 8 million people looking for an apartment have transited the site since its opening in 2016.

The company has been awarded the prestigious FinTech Awards as “best startup in the real estate sector”, is considered among the top 5 Italian startups according to the investment fund Boost Heroes and was recently selected among the best innovative realities in Italy and Southeast Europe by ScaleIT. It also won the “best e-commerce startup for Southern Europe” award at the SESA AWARDS 2019.

Homepal’s round will close on April 12th and has already raised $2.4 million (€2 million) to date.

__

(Featured image by Maklay62 via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Crowdfunding buzz, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.